Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,100 INR | +0.41% | -2.95% | +0.46% |
May. 03 | Astec Lifesciences' CFO Resigns | MT |
May. 02 | Astec LifeSciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
Sales 2024 | 4.58B 55.13M | Sales 2025 * | 6.76B 81.29M | Capitalization | 21.49B 259M |
---|---|---|---|---|---|
Net income 2024 | -469M -5.64M | Net income 2025 * | 579M 6.97M | EV / Sales 2024 | 4.57 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.18 x |
P/E ratio 2024 |
-44.6
x | P/E ratio 2025 * |
37.1
x | Employees | 551 |
Yield 2024 * |
-
| Yield 2025 * |
0.09% | Free-Float | 29.63% |
1 day | +0.41% | ||
1 week | -2.95% | ||
Current month | +0.41% | ||
1 month | -10.70% | ||
3 months | +21.42% | ||
6 months | -4.77% | ||
Current year | +0.46% |
Managers | Title | Age | Since |
---|---|---|---|
Anurag Roy
CEO | Chief Executive Officer | 50 | 21-07-27 |
Founder | 69 | 94-01-24 | |
Compliance Officer | - | 18-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 72 | 15-10-11 | |
Director/Board Member | - | 22-07-24 | |
Director/Board Member | 59 | 15-10-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 1,100 | +0.41% | 74 348 |
24-05-31 | 1,096 | -1.37% | 16,601 |
24-05-30 | 1,111 | -0.19% | 18,501 |
24-05-29 | 1,113 | -1.22% | 14,666 |
24-05-28 | 1,127 | -0.60% | 24,837 |
Delayed Quote NSE India S.E., June 03, 2024 at 07:43 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.46% | 257M | |
+16.74% | 38.99B | |
-.--% | 11.36B | |
-3.33% | 7.61B | |
+3.82% | 6.45B | |
-4.62% | 6.17B | |
-2.74% | 5.73B | |
+32.88% | 5.25B | |
-12.91% | 5.23B | |
-10.02% | 4.58B |
- Stock Market
- Equities
- ASTEC Stock